Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

NCT03927898 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Toripalimab
RADIATION: Stereotactic Body Radiotherapy

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]